Navigation Links
Polymer-Aide PCR Enhancer from Sigma-Aldrich

ProductsPolymer-Aide PCR Enhancer from Sigma-Aldrich
Company Sigma-Aldrich
Item Polymer-Aide PCR Enhancer
Price 
Description Templates rich in GC content or with significant secondary structure are often very difficult to amplify, and when subjected to PCR result in little or no product. Yield, specificity and consistency can be increased by the addition of enhancing agents in PCR amplification reactions. Polymer-Aide is an effective PCR enhancer for GC-rich templates.

Polymer-Aide is designed for molecular biology applications and has been tested for the presence of nuclease activity (RNase, DNase, and nickase).

Info Sigma-AldrichSigma-Aldrich
Sigma-Aldrich Corp.
St. Louis, MO, USA
Customer Service: 800-325-3010
Tech Support: 800-325-5832
Fax Number: 314-771-5757
Web Site: http://www.sigmaaldrich.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. MasterAmp 10X PCR Enhancer from EPICENTRE Biotechnologies
2. MasterAmp 10X PCR Enhancer from EPICENTRE Biotechnologies
3. Can Get Signal Immunoreaction Enhancer Solution from Cosmo Bio Co., Ltd.
4. Qentix (tm) Western Blot Signal Enhancer from Pierce Biotechnology, Inc.
5. PCRX Enhancer System from Invitrogen
6. Attoglow Western Blot Analysis Kit: Millennium Enhancer from BioChain
7. Glutathione-S-Transferase (GST) Colorimetric Assay Kit from Sigma-Aldrich
8. ATX Ponceau S red staining solution from Sigma-Aldrich
9. Corning Proculture Spinner Flask,15L,Vertical S/Arm, No. Of S/A 4,Cent Neck 100mm from Sigma-Aldrich
10. Bakers yeast (S. cerevisiae) Phosphoglucose isomerase from Sigma-Aldrich
11. Bakers yeast (S. cerevisiae) S-Acetyl-coenzyme A synthetase from Sigma-Aldrich
GeneRacer is an advanced RACE (rapid amplification of cDNA ends) technique that improves the efficiency of amplifying full-length 5' and 3' cDNA ends. With the GeneRacer Kit you can:...
One-step, microplate or cuvet, colorimetric, linear detection range 0.6 mM to 100 mM. Procedure: 2 min....
[5,6,8,9,12,14,15(n)-3H]Prostaglandin D2, 925 kBq, 25 uCi. Methanol:water:acetonitrile (3:2:1) solution.> 3.0 TBq/mmol, > 80 Ci/mmol.3.7 MBq/ml, 100 uCi/ml. Category: Radiochemicals &Radiation Safety...
EnzChek cellulase substrate *blue fluorescent, 339/452...
Biology Products:
(Date:1/30/2017)... --  Invitae Corporation (NYSE: NVTA ), ... announced that it will report its fourth quarter and ... Monday, February 13, 2017, and Invitae,s management team will ... Eastern / 1:45 p.m. Pacific. During ... results, guidance, and recent developments and will spend the ...
(Date:1/24/2017)... , Jan. 24, 2017 Biopharm Reports ... the laboratory use of nuclear magnetic resonance spectroscopy ... end-users and profiled current practices, developments, trends and ... well as growth and opportunities. These areas include ... NMR instruments, needs and innovation requirements, hyphenated NMR ...
(Date:1/19/2017)... January 19, 2017 According to a new report published ... 2014 - 2022," the global biometric sensor market is expected to garner $1.5 ... In 2015, Asia-Pacific dominated the global market and contributed ... Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; ... Friday, February 24, 2017 a total of 10,672,750 common share ... per common share. Proceeds from the exercise of these warrants ... Treasury.   ... "We are grateful for this expression of confidence by our ...
(Date:2/27/2017)... , Feb. 27, 2017 Fluxion Biosciences ... Spain has been appointed as a Certified ... The IsoFlux system will be used in Genetracer Biotech,s ... to lung and colon cancer, with plans to move ... laboratory is utilizing Fluxion,s IsoFlux System to isolate, recover, ...
(Date:2/25/2017)... , ... February 25, 2017 , ... ... Verified Clinical Trials in an ongoing effort to create meaningful change by ... and pharmaceutical research with emphasis on consumers and patients’ mental health well-being. , ...
(Date:2/24/2017)... Feb. 24, 2017 Provectus Biopharmaceuticals, Inc. ... "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, ... to participate in its previously announced rights offering ... shares of common stock and Series C Convertible ... listed warrants. As previously announced, ...
Breaking Biology Technology: